SCHEMBL1789637

SCHEMBL1789637

CC(C)(C)C1[C@@H](Sc2ccc3nc(N)sc3c2)CCN1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
LMNA P02545 2/20 0.39
HSD11B1 P28845 2/20 0.37
EPHX2 P34913 1/20 0.37
MAPT P10636 3/20 0.36
RAB9A P51151 3/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 2/20 0.36
NPC1 O15118 2/20 0.36
VDR P11473 1/20 0.36
HPGD P15428 1/20 0.36
GFER P55789 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36
PIK3CA P42336 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1785923 1.00 KCNH2 (0.42) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1791054 0.77 ALDH1A1 (0.47) CYP1A2CYP3A4CYP2D6CYP2C9LMNA
SCHEMBL1785498 0.77 ALDH1A1 (0.47) CYP1A2CYP3A4CYP2D6CYP2C9LMNA
SCHEMBL1785477 0.76 CYP1A2 (0.48) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1786538 0.75 CYP1A2 (0.47) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1788290 0.75 CYP1A2 (0.47) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1787307 0.75 CYP1A2 (0.47) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1786393 0.73 PIK3CA (0.54) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1785921 0.72 PIK3CA (0.51) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1789635 0.72 PIK3CA (0.51) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110124621-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124621-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS GPR119, GHSR, GLP1R KCNH2 1919/4885CYP1A2 3643/4885CYP3A4 3775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.